Cannabis clinic and charity to assess the benefits of medical cannabis for insomnia

25th November 2021

One of the UK’s largest medical cannabis clinics, in partnership with a charity specialising in improving sleeping, will hold a panel on how cannabis can affect our wellbeing and sleep quality.

The Sapphire Institute for Medical Cannabis Education has partnered with The International Sleep Charity (ISC), a registered UK charity, with a mission to improve global wellbeing through sleep education.

In December, the two will jointly host global researchers and clinicians to discuss medical cannabis for sleep and insomnia.

Sleep quality is an important aspect of a healthy life, however, research consistently shows that a significant proportion of the population suffers from poor sleep and sleep conditions such as insomnia. In fact, research shows that one in three people in the UK suffers from insomnia or other sleep conditions.

During the roundtable, global experts will review the existing evidence for the potential of medical cannabis and cannabinoids in the treatment of impaired sleep, including randomised controlled trials, as well as sharing the latest research projects, trials and patient outcomes.

The event will take place online on Wednesday 8 December at 8.00 am GMT and is open to everyone for free – you can register here on this link.

Speakers include

  • Professor Ron Grunstein – Professor of Sleep Medicine at the University of Sydney and lead of the Sleep and Circadian Research Group at the Woolcock Institute. He is the principal investigator on the CANSLEEP trial.
  • Dr Jen Walsh – Lecturer at the Centre for Sleep Science in the School of Human Sciences at The University of Western Australia and a research fellow at the West Australian Sleep Disorders Research Institute. She recently published the results of the ZTL-INS-201, a trial investigating medical cannabis in insomnia.
  • Dr Mark Weatherall – Consultant Neurologist at Sapphire Medical Clinics prescribing medical cannabis for a range of neurological conditions including treatment-resistant insomnia.
  • Dr Simon Erridge, Clinical Research Fellow at Imperial College London and Head of Research and Access at Sapphire Medical Clinics

Dr Connor Qiu, Co-founder of the International Sleep Charity, said: “Medical cannabis as a treatment option is a novel and interesting area for impactful translational research.

“By partnering with the Sapphire Institute for Medical Cannabis Education, we host a panel of international experts to add to this dialogue, in keeping with The International Sleep Charity’s ultimate aim of helping as many people as possible to sleep better.”

Dr Mikael Sodergren, Managing Director and Academic Lead at Sapphire Medical Clinics, added: “We are delighted to partner with the International Sleep Charity, which seeks to help millions of people across the globe improve their health and well-being by sleeping better, through education and key initiatives.

“Sleep disorders are thought to affect at least 20% of the population and cannabis and cannabinoid-based products are increasingly consumed by a wide demographic seeking to improve sleep conditions such as insomnia but also for patients with other chronic conditions where sleep is negatively impacted such as chronic pain and anxiety.

“We look forward to the knowledge exchange between Sapphire Institute for Education, ISC and patients around the world who seek a better night’s rest.”

Related Stories